Clinical Trials · NCT06914895
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 905
- Start date
- Apr 2025
- Locations
- 146 sites, 12 countries
- Primary endpoint
- Change from Baseline in Hemoglobin A1c (HbA1c)